Press Releases

FRANKFURT, GERMANY - Oct 11, 2017 - Platinum Global Solutions’ has continued its practice of promoting business development across all the Pharma/ Biotech companies through a healthy and constructive gathering from all the top leading Pharma/ Biotech companies from all across the world. Multiple thought provoking themes ranging from the future of clinical trials, addressing budgeting and financial issues, Technology Implementations, Strategic relationship of Sponsors and many more innovations of the industry were discussed under the umbrella of Genesis Clinical Trials.

At GCT 2017, various Pharmaceutical and Biotech companies were gathered under one roof to share their knowledge and experiences. Best practices from companies across industries were shared along with strategic keynote presentations by industry thought leaders from the field of Clinical Trials. The Future of Clinical Trials, New Technology implementations and its future outcomes was stressed upon at the Summit. The key takeaway from the Summit was to inculcate the concept of long-term thinking, involving risk management and mitigation, handling CRO’s, broader visions of data insights and a broader perceptive of Clinical Trials phases in the mindsets of Pharma and Biotech companies.

Companies were given opportunities to develop their business via presentations, giving their product demos at the exhibition spaces provided to them. The biggest highlight of the event was the pre-scheduled ONE to ONE partnering meetings with the decision makers of their choice.

The highest scoring companies were recognized to be the part of Genesis Clinical Trials during the two days dedication to Clinical Trials customs and forecasts.

Showcasing this concept were some presentations given by:
• Dr Gareth Worthington, Director Scientific Affairs; Shire
• Julien Nicolas Grogg, Director of Clinical Operations; MaxiVax
• Dmitry Manuilov, Quality Assurance Head; Maxwell
• John Shilling ford, Senior Consultant; Orsus Medical
• Prof. Dr. Yasar Ilker Kanzik, Co-founder and Managing Director; IDEAL Pharma Consulting
• Dr. Matthias Breugelmans, GI Business Transformation Consultant; Grunenthal
• Youlia Nazaretyan, Quality and Training Manager; MedTrans Service
• Anne Tingsgård, Vice President, Regulatory Affairs Services; KLIFO
• Nikola Strumberger, Vice President Business Development; Optimapharm
• Dimitar Mihaylov, Business Development Manager; Ramus Medical
• Ursula Garczarek, Associate Director; Cytel
• Dr. Yvonne Rollinger, Managing Director; OmniComm Systems
• Margarete Rudolf, Director Monitoring Data Flow Optimization; Covance

Platinum Global Solutions strongly emphasizes a concise and structured framework that needs to be adopted by organizations in order to excel in their sustainability initiatives, evolving from long-term risk identification, building a sustainable future in the field of clinical trials, and understanding stakeholder requirements. Organizations need to balance their business’ economic challenges with a sound and clear understanding of the environmental and social impact along with a concrete action plan for mitigating the same.

Moving forward, Platinum Global Solutions plans to increase the scope of Clinical Trials “Transforming the Future of Healthcare” to gain a wider spectrum of visibility and enhance learning among corporates from all over the world.
Overall the event was a great success for Platinum Global Solutions.

If you would like more information about 2nd Annual Genesis Clinical Trials or Platinum Global Solutions, you can contact on 44 20 77 89 1109 or visit www.pgsolx.com